Tg Therapeutics, Inc. financial data

Symbol
TGTX on Nasdaq
Location
New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 427 % +0.69%
Quick Ratio 98.4 % +34.4%
Debt-to-equity 121 % -16.8%
Return On Equity -354 %
Return On Assets 60.4 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 159M shares +1.99%
Common Stock, Shares, Outstanding 155M shares -0.36%
Entity Public Float 2.5B USD -26.5%
Common Stock, Value, Issued 159K USD +1.92%
Weighted Average Number of Shares Outstanding, Basic 145M shares +0.22%
Weighted Average Number of Shares Outstanding, Diluted 161M shares +0.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 532M USD +101%
Research and Development Expense 143M USD +62.6%
Costs and Expenses 429M USD +61.8%
Operating Income (Loss) 103M USD +136%
Nonoperating Income (Expense) -15M USD -12.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 87.8M USD +507%
Income Tax Expense (Benefit) -360M USD -94169%
Net Income (Loss) Attributable to Parent 447M USD +9975%
Earnings Per Share, Basic 3 USD/shares +8867%
Earnings Per Share, Diluted 2 USD/shares +12050%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 74.1M USD -62.2%
Cash, Cash Equivalents, and Short-term Investments 178M USD -47.7%
Accounts Receivable, after Allowance for Credit Loss, Current 265M USD +129%
Inventory, Net 147M USD +73.6%
Other Assets, Current 55.8M USD +71.1%
Assets, Current 600M USD +4.48%
Deferred Income Tax Assets, Net 367M USD
Property, Plant and Equipment, Net 66K USD -72.2%
Operating Lease, Right-of-Use Asset 6.5M USD -12.3%
Goodwill 799K USD 0%
Other Assets, Noncurrent 2.05M USD -3.26%
Assets 1.03B USD +74.9%
Liabilities, Current 157M USD +25.3%
Operating Lease, Liability, Noncurrent 7.31M USD -13.2%
Liabilities 418M USD +6.08%
Retained Earnings (Accumulated Deficit) -1.11B USD +28.8%
Stockholders' Equity Attributable to Parent 607M USD +216%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 40.5M USD -68.7%
Liabilities and Equity 1.03B USD +74.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.7M USD -250%
Net Cash Provided by (Used in) Financing Activities -6.1M USD -161%
Net Cash Provided by (Used in) Investing Activities -12.9M USD -39.8%
Common Stock, Shares Authorized 190M shares 0%
Common Stock, Shares, Issued 159M shares +1.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -47.8M USD -174%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 75.4M USD -61.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6.14M USD +151%
Deferred Tax Assets, Valuation Allowance 415M USD -0.89%
Deferred Tax Assets, Gross 415M USD -0.89%
Operating Lease, Liability 8.38M USD -13.2%
Depreciation 68K USD -10.5%
Payments to Acquire Property, Plant, and Equipment 25K USD
Lessee, Operating Lease, Liability, to be Paid 11.1M USD -16.5%
Operating Lease, Liability, Current 1.07M USD -13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.91M USD -8.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.08M USD -0.95%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.68M USD -25.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.83M USD -4.5%
Deferred Tax Assets, Operating Loss Carryforwards 294M USD -7.23%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.83M USD 0%
Operating Lease, Payments 500K USD -16.7%
Additional Paid in Capital 1.81B USD +3.75%
Amortization of Intangible Assets 53K USD 0%
Depreciation, Depletion and Amortization 8K USD -72.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 55.1M USD +47.3%
Interest Expense 12.1M USD +16.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%